SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-97-002339
Filing Date
1997-05-13
Accepted
1997-05-13 00:00:00
Documents
4
Period of Report
1997-03-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. 10-Q 26742
2 COMPUTATION OF NET LOSS PER SHARE EX-11 1862
3 FACTORS REGARDING FORWARD LOOKING STATEMENTS EX-99.1 31575
4 FINANCIAL DATA SCHEDULE EX-27 2056
  Complete submission text file 0000950135-97-002339.txt   63923
Mailing Address
Business Address 195 ALBANY STREET CAMBRIDGE MA 02138 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21481 | Film No.: 97602063
SIC: 2836 Biological Products, (No Diagnostic Substances)